Biotech and life sciences
AEO for biotech and life science companies
AEO for biotech is the work of getting your platform, reagent, instrument, software or contract service named and described accurately when a scientist, lab manager, sourcing lead or business development team asks ChatGPT, Google AI Overviews, AI Mode, Perplexity, Gemini or Copilot which provider to use. We work with B2B biotech companies: research tools and reagent suppliers, CROs and CDMOs, lab software vendors and platform biotechs that sell partnerships, in the US, UK, Canada, Australia, India, Singapore and the UAE. You get a baseline of the prompts your buyers type, a map of the papers, marketplaces and trade pages cited today, rebuilt answer-first technical pages, and monthly reporting tied to quote, sample and partnership requests.
Get a free AEO visibility check
Two lines is enough. A specialist replies within one business day.
The short answer
How does a biotech company get recommended by ChatGPT and Google AI Overviews?
AEO for biotech starts with the sources answers already use for scientific buyers: peer-reviewed papers, preprints, trade press, sourcing marketplaces and vendor application notes. Make your data and specifications quotable in plain text, earn mentions in those sources, keep claims inside RUO and investigational rules, and track a fixed prompt set monthly. No one can promise a citation.
Quotable points
- Scientific buyers ask narrow, technical prompts, so pages must state modality, specifications, throughput and validation data in text, not in PDFs.
- Top results for biotech prompts mix literature (PMC, bioRxiv), trade media, sourcing marketplaces and vendor content marketing.
- Publications that use your product are the strongest proof an answer can cite; application notes and benchmarks come next.
- Research Use Only and investigational product rules limit what an answer-first page may claim.
Which biotech companies is AEO built for, and who should skip it?
It suits four kinds of company. Research tools, reagent and instrument suppliers competing on prompts like 'best single-cell platform' or 'antibody for a given target validated in IHC'. CROs and CDMOs, where sourcing and program leads ask assistants to shortlist providers by modality, phase and region. Lab software vendors such as ELN, LIMS and bioinformatics tools, whose buyers behave like B2B SaaS buyers with a scientist's vocabulary. And platform biotechs whose business development teams want the platform named when a partner or investor asks who works on a modality.
It is a poor fit for a company with a marketed drug whose main concern is how patients and prescribers hear about it; that work runs through MLR review and has its own page on our site. Hospitals and clinics belong with our healthcare work. A seed-stage company with no data, no publications and no customers should publish its first preprint or application note before paying for AEO, because an assistant has nothing to cite.
Which biotech buyer prompts do we test, and who wins them today?
Biotech prompts split into four groups. Provider prompts (best CDMO for cell and gene therapy, CRO for preclinical oncology in Europe), platform comparisons (single-cell RNA-seq platform comparison, one sequencing chemistry versus another), tool prompts (best electronic lab notebook for a biotech startup, antibody for a target and application) and partnership prompts (which companies work on in vivo CAR-T or a delivery technology). The table summarizes the top web results we checked on 5 November 2026 with a US-based search tool. It shows who holds the ground answer engines search; it is not a record of any single ChatGPT answer.
The pattern differs from consumer health. Provider prompts go to sourcing guides and marketplaces (PharmaSource, Pharmaoffer), market research pages and the large CDMOs' own expert content (Catalent, Charles River, Cytiva). Platform prompts go to the literature: PMC reviews, bioRxiv benchmarks and GenomeWeb coverage of the ABRF platform comparison. Tool prompts go to review aggregators and to smaller vendors' own guides, such as Scispot and Genemod publishing ELN buying guides. A small company with a clear, dated technical page can sit beside the giants because scientists' questions are specific.
| Biotech buyer prompt | Who led the top web results (checked 5 Nov 2026) | What a company needs to compete |
|---|---|---|
| best CDMO for cell and gene therapy | pharmasource.global, biologics.catalent.com, synapse.patsnap.com, creative-biolabs.com, criver.com, cytivalifesciences.com, pharmaoffer.com | Modality, scale, phase and site pages in plain text, plus marketplace and trade press listings |
| best single cell RNA sequencing platform comparison | biorxiv.org, ncbi.nlm.nih.gov (PMC), genomeweb.com, ultimagenomics.com, frontiersin.org | Benchmark data published as a preprint or paper, and a comparison page citing it |
| best electronic lab notebook for biotech startups | us.fitgap.com, scispot.com, genemod.net, crex.nih.gov, news-medical.net, scientist.com | A 'best for' page by lab size, review profiles and placement in aggregator lists |
What you get
What we deliver
Scoped and quoted at a fixed price after a free review.
Scientific buyer prompt baseline
A fixed set of provider, platform, tool and partnership prompts by modality, application and region, run in each assistant, showing where you appear and who is named instead.
Citation source map
The papers, preprints, trade articles, marketplaces and competitor pages cited for your category, with the gaps where your company is missing.
Technical product and service pages
Answer-first pages with specifications, validation data, limits and a last-updated date, reviewed by your scientists.
Publications and evidence hub
A crawlable list of papers, preprints, posters and application notes that use or describe your product or platform.
Comparison pages
Fair pages against named alternatives that cite independent benchmarks where they exist.
Regulatory claims review
Drafts checked against RUO labeling, investigational product limits and comparative claim rules before your regulatory team signs off.
Crawler and gating review
robots.txt, firewall rules, gated PDFs and JavaScript catalogs checked so OAI-SearchBot, PerplexityBot and Bingbot reach your content.
Request-level reporting
Monthly citation share plus GA4 quote, sample and partnering requests from AI referral sources.
What do citation studies say about biotech in AI answers?
We found no published study that measures AI citations for biotech or life science tools specifically, and we would rather say so than borrow a number. The nearest evidence is from broader B2B and technical buying. The Overthink Group study of 1,263 B2B prompts (June 2026) found that most cited pages had 'best', 'top' or 'leading' in the title, which matches the sourcing guides and ranked lists we see for CDMO and ELN prompts.
On the buyer side, the GlobalSpec and TREW 2026 survey of 572 technical buyers found 69% use generative AI while buying but rate their trust in the answers 4.7 out of 10. Low trust does not mean low influence: a buyer who uses an assistant to build a shortlist still has to check a paper, a datasheet or a vendor page before buying. So the work is to be on the shortlist and to make the verification step land on your own page.
What must a biotech company have to compete in AI answers?
A company needs its technical facts in crawlable text, independent proof that it works, and presence in the places scientists and sourcing teams look. Most biotech sites fail the first test. Specifications live in a gated PDF, application notes need a form, the CRO service page says 'end-to-end solutions' without naming a model system, and the platform page is a video with no transcript.
Off-site, publications that cite your product are the strongest signal, which is why citation databases such as CiteAb and Bioz matter for reagent and instrument suppliers. Preprints on bioRxiv, posters from major meetings, trade coverage in GenomeWeb, BioProcess International or Cell and Gene, and listings on sourcing marketplaces like Scientist.com or PharmaSource all give an answer something to cite. Digital PR aimed at those outlets builds the mentions that help an assistant trust a smaller company.
- One page per product line, modality or service with specifications, validation data and limits in plain text
- Application notes and protocols published as HTML pages, with the PDF as an extra
- A publications page listing papers that used your product or platform, linked to PubMed or the DOI
- Comparison pages that cite independent benchmarks, not only your own data
- Site, capacity and quality pages for CROs and CDMOs: GLP or GMP status, scale and regions served
- Organization and Product schema markup with sameAs links to Wikidata, LinkedIn and marketplace profiles
What regulatory limits shape AEO for biotech?
Answer-first writing pushes you to state outcomes plainly, and biotech rules limit which outcomes you may state. Under 21 CFR 809.10(c), a Research Use Only product must carry the label 'For Research Use Only. Not for use in diagnostic procedures.' and must not be represented as an effective diagnostic. FDA looks at marketing copy as evidence of intended use, so a page written to win a prompt about diagnosing a disease with an RUO assay can create a regulatory problem. Clinical sensitivity, specificity and predictive value claims belong only on cleared products.
For companies with investigational drugs or biologics, 21 CFR 312.7 says a sponsor must not represent in a promotional context that an investigational product is safe or effective for the use under investigation; scientific exchange remains allowed. Platform and pipeline pages should therefore report data and status, not conclusions like 'cures' or 'proven safe'. Comparative claims about competitors still fall under truth-in-advertising law. This is not legal or regulatory advice; your regulatory affairs team has the final word, and we build their review into every page.
How is AEO different for tools vendors, CROs and CDMOs, and platform biotechs?
The method is the same; the prompt set and the proof change. A tools or reagent vendor competes on product and application prompts, so specification pages, citation counts and comparison pages come first, and the work looks like our approach for manufacturers selling technical products. A CRO or CDMO competes on provider shortlists, so modality, phase, capacity, quality status and region pages come first, much like vendor shortlists in other B2B categories.
A platform biotech competes on partnership and investor prompts, where the answer depends on publications, trade press and an accurate company description, so entity work and a clear platform page matter most. Companies selling across countries need region-specific pages for the US, the United Kingdom and Europe, Singapore or India, because sourcing teams often ask for a provider in their region.
How do we measure AEO for biotech against qualified requests?
We measure what reaches your business development and sales teams. Each month we run a fixed prompt set by product line, modality, application and region in ChatGPT, Google AI Mode, AI Overviews, Perplexity, Gemini and Copilot, and record whether you are named, how you are described, which competitors appear and which URL, paper or listing is cited. That produces citation share against named competitors and a list of wrong AI answers to correct, such as a discontinued product or an old site.
In GA4 we separate referrals from chatgpt.com, perplexity.ai, copilot.microsoft.com and gemini.google.com and follow them to quote requests, sample requests, RFP downloads and partnering forms. Search Console's generative AI report and Bing Webmaster Tools AI Performance add first-party data. Sales cycles in this sector are long, so we report leading indicators monthly and pipeline quarterly.
What mistakes do biotech marketers make with AI search?
The most common is gating everything. A spec sheet behind a form is invisible to OAI-SearchBot and PerplexityBot, and the prompt goes to a competitor or a marketplace. The second is vague copy: 'innovative solutions for advanced therapies' answers no scientist's question. The third is ignoring the literature, when a page listing the papers that used your product is often the most citable thing you own. Our technical AEO review also checks robots.txt, firewall rules and JavaScript-only product catalogs.
Others recur in every AEO audit we run: old company names after an acquisition, discontinued products still described as current, claims that cross RUO lines, and treating AI search as separate from SEO, when Google says optimizing for its AI features is still SEO. Our AEO content writing team writes answer-first content that your scientists and regulatory team review before it goes live. If you are comparing quotes, our AEO pricing guide sets out published market ranges.
How it works
How an engagement runs
- 01
Free visibility check
We run a short prompt sample for your main products or services and show where you appear today, then quote a fixed price.
- 02
Baseline and source map
Full prompt set by modality, application and region, cited-source analysis, page inventory and crawler review, ranked by likely impact.
- 03
Rebuild technical pages
Product, service, evidence and comparison pages ship first, each reviewed by your scientists and regulatory team.
- 04
Earn outside proof
Marketplace listings, trade press, preprints and citation database profiles aligned with your site.
- 05
Track and adjust
Monthly prompt runs and GA4 reporting show what moved, and we adjust the next month's work.
FAQ
Frequently asked questions
What is AEO for biotech?
It is answer engine optimization applied to biotech and life science companies: making sure AI assistants name your product, service or platform and describe it accurately when scientists, sourcing teams or partners ask who to work with. It builds on SEO, with more weight on technical detail, publications and trade sources.
Is AEO for biotech different from AEO for pharma?
Yes. Pharma AEO deals with marketed drugs, patients, prescribers and MLR review. Biotech AEO here covers B2B buyers of tools, services and platforms, where the prompts are technical and the proof is publications and data.
Which sources do AI assistants use for biotech questions?
In the web results we checked in November 2026, provider prompts were led by sourcing guides, marketplaces and large CDMOs' expert content, and platform prompts by PMC reviews, bioRxiv preprints and GenomeWeb. We found no published citation study specific to biotech, so we map the sources for your own prompts first.
Can a small biotech company show up in ChatGPT?
Yes, usually for specific prompts: a modality, application, organism or region the large players describe only in general terms. A clear technical page, a publication list and listings on the marketplaces your buyers use give an assistant reasons to name you.
Should we ungate application notes and spec sheets?
For AI visibility, yes, at least as an HTML summary with the key data. Assistants cannot read content behind a form, and scientists verify claims on the page the answer cites.
Can a Research Use Only product be optimized for AI answers?
Yes, for research applications. Pages must keep the RUO statement and avoid diagnostic or clinical performance claims, because FDA can treat marketing copy as evidence of intended use.
How long does AEO take for a biotech company?
Page, gating and crawler fixes can show in prompt results within weeks. Publications, trade coverage and marketplace presence usually take a quarter or more, so we judge progress on the 90-day rerun of the baseline.
Can you promise our company will be recommended by AI assistants?
No one can promise a citation, and no assistant publishes how it ranks sources. We improve the inputs answers draw on and report citation share and qualified requests from AI referrals monthly.
What does AEO for a biotech company cost?
We quote a fixed price after a free AEO visibility check, based on how many product lines, services, regions and pages need work. Our AEO pricing guide lists published market ranges if you want a benchmark first.
Explore
Find your industry and market
AEO services for this industry
Countries we work in
Other industries
Keep reading
Related pages
Get started
Find out what AI says about you
Send your website and three questions your buyers ask. Within one business day we reply with how ChatGPT, Google AI Overviews and Perplexity answer them today, who they cite instead of you, and a fixed-price plan.
- Free AEO visibility check
- Fixed quote before any work starts
- Measured on citations and AI referrals, not promises
Prefer email? info@aeoservicesagency.com
Get a free AEO visibility check
Two lines is enough to start.